Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype
about
Immune Dysfunction in Patients with Chronic Obstructive Pulmonary DiseaseTumor necrosis factor links chronic obstructive pulmonary disease and K-ras mutant lung cancer through induction of an immunosuppressive pro-tumor microenvironmentMunc18b is an essential gene in mice whose expression is limiting for secretion by airway epithelial and mast cellsMuc5b is required for airway defenceDivergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiotaAugmented lung inflammation protects against influenza A pneumonia.Inhaled innate immune ligands to prevent pneumonia.Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi.Airway mucus function and dysfunction.Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae.Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzaeNontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.Perilla frutescens leaf extract inhibits mite major allergen Der p 2-induced gene expression of pro-allergic and pro-inflammatory cytokines in human bronchial epithelial cell BEAS-2B.Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease.Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae.Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.SuperSILAC Quantitative Proteome Profiling of Murine Middle Ear Epithelial Cell Remodeling with NTHi.Inhaled therapeutics for prevention and treatment of pneumoniaThe role of TLR2 and bacterial lipoprotein in enhancing airway inflammation and immunityMucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammationDps promotes survival of nontypeable Haemophilus influenzae in biofilm communities in vitro and resistance to clearance in vivoStimulation of lung innate immunity protects against lethal pneumococcal pneumonia in miceSynergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice.Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs.IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.Airway and lung pathology due to mucosal surface dehydration in {beta}-epithelial Na+ channel-overexpressing mice: role of TNF-{alpha} and IL-4R{alpha} signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatmentMucus hypersecretion in asthma: causes and effectsAllergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice.Curcumin inhibits COPD-like airway inflammation and lung cancer progression in miceSafety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands.Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase.Pathogenesis of inflammation and repair in advanced COPD.Bacterial superinfection following lung inflammatory disorders.The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.
P2860
Q28083093-E1FBD09D-0536-4658-9A33-51A00408B1A3Q28392873-2237B0E6-F7E3-4E4E-8BDE-5BB989939814Q28570408-189DB437-CC7F-4D97-B690-372059CF116DQ28589969-D23DDEBE-EE71-4997-B1E1-6B4D1DFC3F98Q28731877-5A0A4B77-9BB8-4435-A48E-661C55122E96Q30374306-BB8C37AC-659D-4FCF-BB1E-442A4B1676CAQ30398752-03DE33A4-0D08-4447-9244-7342C58245EDQ33601917-90745021-D86F-4241-AB30-6AE5861D4B8BQ33723578-409743D3-3902-4878-8175-C11D7C443ACDQ34253592-7C5E55FB-9542-4969-B6D1-4D3C75729CFBQ34386841-A225A80B-C907-433E-BD61-37A4D3FE7DCFQ34621087-35C26387-A7BF-4F2F-AD13-6DC542D515C5Q34679251-7E231BCE-9B15-4455-B5C0-B83D112EBBF5Q35035274-457E72B9-0AE7-43F7-A1E4-F78CFF6B8022Q35377816-D602A1BD-AFF0-4F85-8156-36A3F5F6A495Q35618493-92A8A1F5-4367-4FC6-886B-5BF672ABA731Q35763410-7C4D769A-6972-4CBA-8FD7-C86B45622EF7Q35813909-8B319064-EDEF-4114-8979-14C95F2C0241Q35897669-B106682E-98F1-496D-B0D5-AE416F841E4CQ35918088-DBE3B8D6-CAD2-4764-AAEA-6EBBF5126496Q35925366-27B712D5-9991-4C6B-B80C-90A6FA3E8F05Q35927593-102FFB89-4668-4194-82EA-ED61FFA86462Q36040700-94EA5816-F3AC-40EA-B5A5-020916F9BDA7Q36159282-29913C60-EFBB-4B07-AD8C-AC3B84DC4C1DQ36718650-DBC7A21D-074E-4724-A273-DAF558A7759EQ36845161-B32D59FD-0EE3-4C03-A69D-A311D03650D3Q36905694-463CCAE9-851B-4E65-8751-69A240865A34Q36963605-D8DC326B-DCA1-48C9-AC7B-4B800668FB49Q37137320-8F1F270B-C36C-4B1B-942C-E59A76F77E50Q37259129-9290F9A9-9F63-4476-84B7-78C76C4A8F7AQ37298992-62EE97AA-8DDA-4B46-B1A4-CDDE1873EFB7Q37437260-10B934AA-6604-4B0A-839A-6CDAA7DB918CQ37558881-03AEA200-C79E-430C-ACFB-E4908B6FFF63Q37582405-BA871DE1-A80A-4C50-954B-E7B84D4FB63CQ37711524-8798558C-63F3-4523-A57E-9A0082D3B556Q38078465-A241D487-0777-4AC9-8F07-F877B015E9BBQ38538384-698D064C-803F-44F1-9DB1-5377ECB04479Q38630989-E8395403-8AF5-4EDA-B8EE-3044C0FEAFEBQ38679715-62811D15-419E-4FAF-B00C-40395E1FFAEAQ38818334-F4162897-A2B2-4298-A811-04059457CB93
P2860
Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@ast
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@en
type
label
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@ast
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@en
prefLabel
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@ast
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@en
P2093
P2860
P356
P1476
Haemophilus influenzae lysate ...... ve pulmonary disease phenotype
@en
P2093
Burton F Dickey
Cecilia G Clement
Christopher M Evans
Elizabeth L Travis
Hays W J Young
M Miguelina De la Garza
Michael J Tuvim
Seyed Javad Moghaddam
Xiaoyan Zou
P2860
P304
P356
10.1165/RCMB.2007-0366OC
P577
2007-12-20T00:00:00Z